Anette Bjerregaard

Anette Bjerregaard is an External Researcher at the Holst Group within the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) at the University of Copenhagen's Faculty of Health and Medical Sciences. Her research centers on neuroendocrine regulation of metabolism and obesity, with emphasis on translational applications.

Her primary research domains include Obesity Research, Metabolic Disorders, and Neuroendocrinology. She investigates neurotensin receptor mechanisms in post-bariatric surgery physiology and develops peptide-based therapeutics targeting melanocortin pathways. Methodologically, her work relies heavily on mouse models of metabolic disease and molecular pharmacology techniques to dissect energy balance regulation.

Recent publications reveal a cohesive research trajectory exploring neuropeptide interventions for obesity. Her 2021 study examined neurotensin receptor deficiency effects on sleeve gastrectomy outcomes, while the 2019 Diabetes paper demonstrated synergistic anti-obesity effects of neurotensin analogs with GLP-1 agonists. This work bridges gastrointestinal surgery, molecular pharmacology, and metabolic physiology to identify novel therapeutic targets.

She operates within the Holst Group at CBMR—a world-leading metabolic research center funded by the Novo Nordisk Foundation—which provides infrastructure for advanced metabolic phenotyping and molecular studies. The group maintains strong collaborations with international obesity research networks, as evidenced by multi-institutional publications.